Hepatitis C virus infection, microRNA and liver disease progression
about
MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsCytokinome profile evaluation in patients with hepatitis C virus infectionMicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patientsTranscriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.Circulating microRNAs in patients with non-alcoholic fatty liver diseaseHepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathwayMicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature.MicroRNAs: Role in Hepatitis C Virus pathogenesisHepatitis C virus infection: establishment of chronicity and liver disease progressionIdentification of risk factors for hepatitis B and C in Peshawar, Pakistan.Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis.Identification and Characterization of Liver MicroRNAs of the Chinese Tree Shrew via Deep Sequencing.Bioinformatics analysis of hepatitis C virus genotype 2a-induced human hepatocellular carcinoma in Huh7 cells.Significance of Serum Cytokeratin-18 in Prediction of Hepatocellular Carcinoma in Chronic Hepatitis C Infected Egyptian Patients.The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study.Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C.MicroRNA-targeting therapeutics for hepatitis C.MicroRNAs: the fine modulators of liver development and function.Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression.Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity.Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis.Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde.MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patients.HCV-induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T-cell development.Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758.Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region.How miRs and mRNA deadenylases could post-transcriptionally regulate expression of tumor-promoting protein PLD.
P2860
Q26773183-ABD6A764-D8B6-4D50-B48F-82083F872E7DQ26849696-BF35B5F4-93C3-4BE6-8F22-9DAD804BA8C4Q28545051-4479EDFC-8AAF-4315-93B5-62724AA98EF3Q33900272-A087E648-E3EE-4B4C-AADE-5B774886D280Q34179239-71546A2D-6D71-45A6-B0EB-24243F3CF1EAQ35111044-96671656-8501-4715-A0C1-80D43B8AE883Q35202304-1B004CDE-BD31-4454-A067-212BE69ED5DCQ35606627-5D9D10B4-CEAA-41EC-81D2-1E5C77AB5FE2Q35728873-8FFE82E9-4038-42A8-87E8-FB35FCF6C2CFQ35982168-39624881-F3D0-472E-AFCD-3839DE78DF76Q36057439-25EB3A82-1042-46A6-8D14-94FE99004924Q36279237-432454BA-982E-441E-B870-2FD64FD21840Q36462963-1EDB77B6-5A35-45C5-8BBA-72405EA1E02CQ36929039-950DFE1C-122B-4A7F-9273-54B7C11B8F7EQ36969738-17BA09C1-1FB6-4F87-8E33-3F5F04F67FC5Q37073281-1266632B-C858-4578-83F3-38C5B55BD45CQ37252581-CB402920-5B6C-4319-AFF0-744780001E89Q37309033-0D9BAAD6-432E-4831-AA39-2DA50EC78BAAQ38175359-7C9C51DF-2621-4BBE-A77F-7D340590FAB9Q38187190-5FE6E6F5-5A5E-48FC-A66D-F4C6A3756B79Q38212153-91B84787-DD90-4569-BF8F-C47EE3290B5CQ38223363-EE940C81-82B6-4560-9264-EB2C21ECBF6EQ38650644-8B637424-2C03-4E50-A017-712F4A82CCBEQ38779932-FF617491-653D-4911-9E9F-DF0CEC48B889Q38899741-74559E9A-F6D1-4CF0-B831-2F5A009B57BAQ39881002-CEBC256A-5BD8-4521-8C4E-EAFFEBE92092Q40745016-8A72924C-110D-4738-A493-4096E7440952Q42206825-1504CC62-7210-466A-82FF-D69941BD15BFQ47335897-7D229280-6F2D-45CE-8AB5-862A5B7E1E67Q47721202-3D44B73A-D9FE-4EBD-AFB7-A2BA73654B37
P2860
Hepatitis C virus infection, microRNA and liver disease progression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis C virus infection, microRNA and liver disease progression
@en
Hepatitis C virus infection, microRNA and liver disease progression.
@nl
type
label
Hepatitis C virus infection, microRNA and liver disease progression
@en
Hepatitis C virus infection, microRNA and liver disease progression.
@nl
prefLabel
Hepatitis C virus infection, microRNA and liver disease progression
@en
Hepatitis C virus infection, microRNA and liver disease progression.
@nl
P2860
P50
P356
P1476
Hepatitis C virus infection, microRNA and liver disease progression
@en
P2860
P304
P356
10.4254/WJH.V5.I9.479
P577
2013-09-01T00:00:00Z